In the last trading session, 2.17 million Neuronetics Inc (NASDAQ:STIM) shares changed hands as the company’s beta touched 2.10. With the company’s per share price at $4.46 changed hands at $0.33 or 7.99% during last session, the market valuation stood at $178.71M. STIM’s last price was a discount, traded about -13.68% off its 52-week high of $5.07. The share price had its 52-week low at $0.52, which suggests the last value was 88.34% up since then.
Analysts gave the Neuronetics Inc (STIM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended STIM as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Neuronetics Inc’s EPS for the current quarter is expected to be -0.24.
Neuronetics Inc (NASDAQ:STIM) trade information
Instantly STIM was in green as seen at the end of in last trading. With action 2.29%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 177.02%, with the 5-day performance at 2.29% in the green. However, in the 30-day time frame, Neuronetics Inc (NASDAQ:STIM) is 86.61% up.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 44.25% from its current market value. According to analyst projections, STIM’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -79.37% plunge from its current level, while the stock would need to soar -79.37% for it to hit the projected low.
Neuronetics Inc (STIM) estimates and forecasts
Year-over-year growth is forecast to reach 0.01% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 18.98M. 1 analysts are of the opinion that Neuronetics Inc’s revenue for the current quarter will be 28.8M. The company’s revenue for the corresponding quarters a year ago was 20.31M and 17.42M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -6.55%. The estimates for the next quarter sales put growth at 65.36%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.12%. The 2025 estimates are for Neuronetics Inc earnings to decrease by -20.95%, but the outlook for the next 5-year period is at 28.12% per year.
STIM Dividends
Neuronetics Inc is expected to release its next quarterly earnings report in March.
CANNELL CAPITAL LLC holds the second largest percentage of outstanding shares, with 7.9239% or 2.38 million shares worth $4.29 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 849.5 shares estimated at $3.79 million under it, the former controlled 2.80% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.33% of the shares, roughly 403.88 shares worth around $1.8 million.
